- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01839474
CPAP Survival Study in Ghana
Clinical Trial Evaluating the Difference in Mortality Rates in Children in Ghana Receiving CPAP Versus Those Who Do Not
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute respiratory infections, malaria, and sepsis remain leading causes of death in children throughout the world.These conditions may lead to respiratory distress and eventually failure if not adequately managed. In developing countries with limited resources, advanced airway management and support can be challenging and needs to be approached in a different manner than is done in developed nations. For example, the use of invasive mechanical ventilation for respiratory distress is not an option in many resource-limited countries due to the lack of available technology, infrastructure, and trained personnel. Other alternatives should be utilized in order to support children with reversible conditions during their acute respiratory distress stage. One such alternative is non-invasive positive pressure.
Prior research demonstrated that nasal bubble CPAP can be successfully introduced and utilized in a developing country's emergency ward. Nurses in four Ghanaian district hospital emergency wards (Kintampo, Mampong,Nkoranza, and Wenchi) were able to safely apply CPAP and monitor the patient's response. The investigators demonstrated that patients receiving CPAP had a significant decrease in respiratory rate compared with those that did not with a mean difference of 14 breaths per minute. There were no major side effects associated with the use of CPAP. Now that CPAP has demonstrated to decrease respiratory rate in a non-specific disease population presenting with respiratory distress it is important to determine if it also improves survival. Therefore, the purpose of the study is to determine if the use of CPAP in children 1 month to 5 years of age with respiratory distress decreases mortality.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ashanti Region
-
Mampong, Ashanti Region, Ghana
- Mampong District Hospital
-
-
Brong Ahafo
-
Kintampo, Brong Ahafo, Ghana
- Kintampo District Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- One month to five years of age
- Respiratory rate (RR) greater than 50 breaths per minute in three months to one year of age, and greater than 40 breaths per minute in one to five years of age
- Presence of sub costal, intercostal, supraclavicular retractions or nasal flaring
Exclusion Criteria:
- Age less than one month or older than five years
- Skin breakdown around nose/mouth or facial trauma
- Unable to protect airway
- Uncontrollable emesis
- Unresponsiveness
- poor respiratory effort requiring positive pressure ventilation or invasive mechanical ventilation for respiratory failure
- known or suspected pneumothorax
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CPAP
Children will be placed on nasal CPAP until they have an age appropriate respiratory rate and receive standard medical therapy.
|
Appropriately sized nasal prongs will be selected for the patient, gently applied ensuring a tight seal, and securely fastened.
The CPAP machine will be turned on to deliver a pressure of 5 cm H2O in the inspiratory limb of the system.
Patients will be allowed to be in the position of most comfort, preferably with mouth closed to maintain pressure in the circuit.
Other Names:
|
|
No Intervention: Control
Children will receive standard medical therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
All cause mortality
Time Frame: 2 weeks
|
The primary outcome will be 2 week mortality rate in children receiving CPAP and standard therapy compared with children receiving standard therapy alone.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory rate
Time Frame: 24 hours
|
To measure change in respiratory rates between children receiving CPAP compared to those who do not for 24 hours.
|
24 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evidence of viral respiratory infection
Time Frame: baseline (at time of enrolment)
|
To determine the etiology of respiratory distress.
We will test nasopharyngeal swabs for common pediatric viruses.
|
baseline (at time of enrolment)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rachel T Moresky, MD, MPH, Columbia University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAJ7954
- GENERAL ELECTRIC FOUNDATION (Other Grant/Funding Number: PT-AABF5157)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
Clinical Trials on CPAP
-
Centre Hospitalier Intercommunal CreteilPr Xavier DURRMEYERNot yet recruitingNeonatal Respiratory DistressFrance
-
State Key Laboratory of Respiratory DiseaseCompletedSleep Apnea, Obstructive | Continuous Positive Airway Pressure | PolysomnographyChina
-
University of ZurichSwiss National Science FoundationCompleted
-
Chinese University of Hong KongCompleted
-
The Hospital for Sick ChildrenCompletedObesity | Cardiovascular Disease | Obstructive Sleep Apnea | Sleep DisordersCanada
-
Federal University of São PauloRecruitingObstructive Sleep Apnea (OSA)Brazil
-
Krishna M. SundarCompleted
-
University Hospital, GrenobleCompleted
-
University Hospital, LilleCompletedSleep Apnea Syndromes | Epilepsies, PartialFrance
-
Ohio State UniversityCompletedHeart Failure | Obstructive Sleep Apnea | Heart Failure, CongestiveUnited States